Mariateresa Acanfora

Dr. Mariateresa Acanfora

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
SRSara Rossi
Sara Rossi
SGSfratta Greta
Sfratta Greta
Mariateresa AcanforaMariateresa Acanfora
Mariateresa Acanfora
MAMaria Benedetta Anesini
Maria Benedetta Anesini
Marianna MazzaMarianna Mazza
Marianna Mazza
Emerging evidence highlights the critical role of the gut microbiota in the development and progression of eating disorders (EDs), particularly in women, who are more frequently affected by these conditions. Women with anorexia nervosa, bulimia nervosa, and binge eating disorder exhibit distinct alterations in gut microbiota composition compared to healthy controls. These alterations, collectively termed dysbiosis, involve reduced microbial diversity and shifts in key bacterial populations responsible for regulating metabolism, inflammation, and gut–brain signaling. The gut microbiota is known to influence appetite regulation, mood, and stress responses—factors closely implicated in the pathogenesis of EDs. In women, hormonal fluctuations related to menstruation, pregnancy, and menopause may further modulate gut microbial profiles, potentially compounding vulnerabilities to disordered eating. Moreover, the restrictive eating patterns, purging behaviors, and altered dietary intake often observed in women with EDs exacerbate microbial imbalances, contributing to intestinal permeability, low-grade inflammation, and disturbances in neurotransmitter production. This evolving understanding suggests that microbiota-targeted therapies, such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT), could complement conventional psychological and pharmacological treatments in women with EDs. Furthermore, precision nutrition and personalized microbiome-based interventions tailored to an individual’s microbial and metabolic profile offer promising avenues for improving treatment efficacy, even though these approaches remain exploratory and their clinical applicability has yet to be fully validated. Future research should focus on sex-specific microbial signatures, causal mechanisms, and microbiota-based interventions to enhance personalized treatment for women struggling with eating disorders.

8 June 2025 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
MAMaria Benedetta Anesini
Maria Benedetta Anesini
MMMiriam Milintenda
Miriam Milintenda
Mariateresa AcanforaMariateresa Acanfora
Mariateresa Acanfora
CCClaudia Calderoni
Claudia Calderoni
Marianna MazzaMarianna Mazza
Marianna Mazza
Neuroimaging has emerged as an innovative and essential tool for understanding the intricate relationship between brain development, emotions, and behavior. Investigating the neurobiological mechanisms underlying this interaction during the critical phase of brain maturation is crucial for promoting individual psychological well-being and mitigating the profound impact of mood disorders during childhood. This narrative scoping review synthesizes current pediatric neuroimaging evidence, filling a gap in the literature by integrating structural, functional, and emerging modalities, to provide clear translational pathways for clinical and behavioral observations. The contribution of major neuroimaging techniques, including fMRI, PET, DTI, and sMRI, is analyzed, emphasizing their ability to detect structural and functional alterations associated with mood disorders, enabling early diagnosis and personalized therapeutic strategies. Furthermore, the potential of these technologies to monitor the effects of psychotherapy is explored, demonstrating how such interventions can modulate neural circuits and enhance emotional processing. Despite significant advancements and growing interest, challenges remain, including the complexity of data interpretation, technological limitations, and ethical considerations related to the use of these interventions in pediatric populations. This review synthesizes the most recent scientific evidence, underscoring the potential of neuroimaging to improve diagnostic accuracy and therapeutic outcomes, while outlining future research directions aimed at enhancing interventions for children and adolescents with mood disorders.

31 July 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
Georgios KotzalidisGeorgios Kotzalidis
Georgios Kotzalidis
MAMaria Benedetta Anesini
Maria Benedetta Anesini
SBSara Barbonetti
Sara Barbonetti
SRSara Rossi
Sara Rossi
Marianna MazzaMarianna Mazza
Marianna Mazza
Background/Objectives: Autism spectrum disorder (ASD) has been extensively studied through neuroimaging, primarily focusing on grey matter and more in children than in adults. Studies in children and adolescents fail to capture changes that may dampen with age, thus leaving only changes specific to ASD. While grey matter has been the primary focus, white matter (WM) may be more specific in identifying the particular biological signature of the neurodiversity of ASD. Diffusion tensor imaging (DTI) is the more appropriate tool to investigate WM in ASD. Despite being introduced in 1994, its application to ASD research began in 2001. Studies employing DTI identify altered fractional anisotropy (FA), mean diffusivity, and radial diffusivity (RD) in individuals with ASD compared to typically developing (TD) individuals. Methods: We systematically reviewed literature on 21 May 2025 on PubMed using the following strategy: (“autism spectrum”[ti] OR autistic[ti] OR ASD[ti] OR “high-functioning autism” OR Asperger*[ti] OR Rett*[ti]) AND (DTI[ti] OR “diffusion tensor”[ti] OR multimodal[ti] OR “white matter”[ti] OR tractograph*[ti]). Our search yielded 239 results, of which 26 were adult human studies and eligible. Results: Analysing the evidence, we obtained regionally diverse WM alterations in adult ASD, specifically in FA, MD, RD, axial diffusivity and kurtosis, neurite density, and orientation dispersion index, compared to TD individuals, mostly in frontal and interhemispheric tracts, association fibres, and subcortical projection pathways. These alterations were less prominent than those of children and adolescents, indicating that individuals with ASD may improve during brain maturation. Conclusions: Our findings suggest that white matter alterations in adults with ASD are regionally diverse but generally less pronounced than in younger populations. This may indicate a potential improvement or adaptation of brain structure during maturation. Further research is needed to clarify the neurobiological mechanisms underlying these changes and their implications for clinical outcomes.

9 June 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
Mariateresa AcanforaMariateresa Acanfora
Mariateresa Acanfora
LCLuca Conci
Luca Conci
GTGianandrea Traversi
Gianandrea Traversi
Osvaldo MazzaOsvaldo Mazza
Osvaldo Mazza
Marianna MazzaMarianna Mazza
Marianna Mazza
Growing evidence indicates that the gut microbiota is not a static ecosystem but a rhythmic metabolic organ whose oscillatory activity is tightly coordinated with host circadian biology. Disruption of this temporal alignment, through irregular diet, sleep disturbance, shift work, or social jet lag, may profoundly alter microbial composition and the production of neuroactive metabolites. These alterations have emerged as potential contributors to the pathophysiology of mood disorders. This review introduces the concept of chrono-metabolic psychiatry, a framework integrating circadian rhythms, gut microbiota dynamics, and host metabolic signaling in the development and course of depressive and bipolar disorders. In this framework, the term “chrono-metabolic” refers to the integration of biological timing, host metabolic regulation, and microbiota-derived metabolic signaling. Chrono-metabolic psychiatry therefore shifts the focus from static dysbiosis or neurotransmitter imbalance alone to the time-dependent interactions among circadian misalignment, microbial rhythmicity, immune regulation, metabolite production, and affective instability. Diurnal fluctuations in short-chain fatty acids, tryptophan–kynurenine metabolites, bile acids, and microbial-derived neurotransmitters interact with clock gene regulation, hypothalamic–pituitary–adrenal axis activity, neuroinflammation, and synaptic plasticity. Chrono-disruption may represent a transdiagnostic vulnerability factor and may confirm the bidirectional relationship between mood instability and microbiota rhythmicity. Emerging therapeutic implications, including chrono-nutrition, time-restricted feeding, targeted probiotic administration (“chronobiotics”), and the microbiota-modulating effects of psychotropic medications are discussed. By shifting from a compositional to a temporal–metabolic perspective, this model highlights the importance of microbial oscillations rather than static dysbiosis alone. Integrating circadian biology into microbiota research may enable metabolomic stratification and pave the way for precision psychiatry approaches grounded in host–microbe metabolic crosstalk. Future longitudinal and time-resolved multi-omics studies are needed to validate this framework and to translate it into clinically actionable interventions.

15 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
Mariateresa AcanforaMariateresa Acanfora
Mariateresa Acanfora
GMGiuseppe Mandracchia
Giuseppe Mandracchia
GTGianandrea Traversi
Gianandrea Traversi
Osvaldo MazzaOsvaldo Mazza
Osvaldo Mazza
Marianna MazzaMarianna Mazza
Marianna Mazza
Complex psychosis (CP) remains one of the most challenging conditions in mental health, characterized by persistent symptoms, cognitive impairment, functional disability, and reduced autonomy. Traditional rehabilitation approaches, although essential, are often insufficient to address the multidimensional needs of these individuals. Over the past decade, rapid advances in digital health have opened new opportunities to enhance psychosocial rehabilitation, improve engagement, and personalize treatment pathways. This narrative review synthesizes current evidence on the use of digital and immersive technologies in the rehabilitation of people with CP, including virtual reality (VR), augmented reality (AR), telerehabilitation platforms, mobile health (m-Health) applications, digital phenotyping, and AI-assisted cognitive remediation. We examine clinical trials, feasibility studies, and real-world implementations published between 2015 and 2025, highlighting the efficacy of VR-based social cognition training, remote cognitive remediation, ecological momentary interventions, and hybrid digital–in-person rehabilitation models. Mechanisms of action, transfer to real-world functioning, and predictors of engagement are described. Barriers such as digital literacy, access disparities, privacy concerns, and clinical integration are critically discussed. We also outline future directions, including adaptive algorithms, biosensor integration, and the development of multimodal digital ecosystems tailored to individual recovery trajectories. By integrating technological innovation with recovery-oriented care, digital rehabilitation tools have the potential to transform the treatment landscape for people with CP. This review offers a roadmap for clinicians, researchers, and policymakers seeking to incorporate evidence-based digital solutions into modern psychiatric rehabilitation.

28 September 2026 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
Giuseppe MaranoGiuseppe Marano
Giuseppe Marano
Mariateresa AcanforaMariateresa Acanfora
Mariateresa Acanfora
LCLuca Conci
Luca Conci
GTGianandrea Traversi
Gianandrea Traversi
DNDaniele Napolitano
Daniele Napolitano
Marianna MazzaMarianna Mazza
Marianna Mazza
Sleep disturbances are common across affective disorders and may coexist with traumatic stress and persistent hyperarousal. This narrative review examines how trauma-related hyperarousal and sleep dysfunction are associated with major depressive disorder (MDD) and bipolar disorder (BD), while distinguishing observed associations from proposed mechanisms. A targeted search of PubMed, Scopus, and Google Scholar identified clinical, neurobiological, and translational literature on trauma, hyperarousal, insomnia, nightmares, circadian disruption, MDD, and BD. The evidence supports a multidimensional view of hyperarousal involving partly overlapping autonomic, cognitive–attentional, affective, and behavioral domains; however, it does not establish hyperarousal as a unitary mechanism or justify equating trauma-related vigilance with manic activation. Sleep disturbance may function as a symptom, vulnerability factor, or prodromal change, but no single sleep measure is currently a validated individual-level prognostic marker. Clinically, trauma history, sleep phenotype, affective state, comorbidity, medication effects, and current safety should be assessed jointly. Cognitive behavioral therapy for insomnia and established trauma-focused treatments have the strongest clinical basis within their indicated populations, whereas imagery rehearsal therapy, prazosin, chronobiological strategies, and candidate biomarkers require diagnosis-specific and evidence-graded interpretation. Longitudinal studies integrating objective sleep measures and explicit temporal modeling are needed before proposed pathways or precision approaches can be considered clinically validated.